Quantcast
Last updated on April 18, 2014 at 6:54 EDT

Latest Percodan Stories

2013-01-29 16:23:26

In the news release, Underage Kids Get Hydrocodone Drugs Easily from Family & Friends, Advises New York Center for Living, issued 28-Jan-2013 by New York Center for Living over PR Newswire, we are advised by a representative of the company that as a result of editing errors the annexed press release contained certain factual inaccuracies in its original form. The release should have been as written below in its entirety. Underage Kids Get Hydrocodone Drugs Easily from Family &...

2013-01-28 20:21:06

NEW YORK, Jan. 28, 2013 /PRNewswire/ -- Sunday's front page of The New York Times New York edition headlined, "F.D.A. Likely to Add Limits on Painkillers," an advisory panel to the Food and Drug Administration voted 19 to 10 to recommend increased restrictions on hydrocodone products, the country's most widely used narcotic painkillers. Painkillers now take the lives of more Americans than heroin and cocaine combined, and since 2008, drug-induced deaths have outstripped those from...

2012-04-05 14:21:05

BEVERLY HILLS, Calif., April 5, 2012 /PRNewswire/ -- According to recent figures released by the Associated Press (AP), sales of oxycodone and hydrocodone increased dramatically between 2000 and 2010, and distribution of those painkillers has exploded in new parts of the country. Administrative director for WAISMANN METHOD® rapid detox treatment and registered addiction specialist, Clare Waismann, is cautioning Americans that this report provides evidence of a prescription painkiller...

2012-01-09 07:30:00

CHADDS FORD, Pa., Jan. 9, 2012 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced that, as a result of a temporary shut-down of Novartis Consumer Health Inc.'s Lincoln, Neb., manufacturing facility, there will be a short-term supply constraint of OPANA® ER. The company also announced certain other Endo analgesic products manufactured at this facility may experience short-term supply disruptions. Endo is working closely with the U.S. Food and Drug...

2011-03-05 22:18:00

TALLAHASSEE, Fla., March 5, 2011 /PRNewswire-USNewswire/ -- The Florida Society of Pain Management Providers (www.Flspmp.org) urges all to cease with the ridiculous comparisons of pain clinics to McDonald's(TM) and work to solve the issue of Rx diversion without resorting to such tactics. To make McDonald's(TM) comparisons to pain management clinics where the vast majority are staffed with (or operated by) respectable, well trained physicians who provide necessary and legitimate care to...

2010-07-20 15:30:00

CHADDS FORD, Pa., July 20 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) will announce its second quarter 2010 financial results on July 30, 2010 and will host a conference call and webcast at 10:00 a.m. ET that day to discuss these results. David P. Holveck, president and CEO of Endo, Julie McHugh, chief operating officer, Dr. Ivan Gergel, executive vice president of R&D, and Alan Levin, executive vice president and chief financial officer and Blaine Davis, vice...

2010-07-19 06:30:00

CHADDS FORD, Pa., July 19 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) CEO Dave Holveck, along with company executives, will mark Endo's 10th anniversary as a publicly traded company by ringing the opening bell at the NASDAQ Marketsite on Monday, July 19, in Times Square in New York. Endo and its employees will be recognizing this milestone at an important juncture in the company's history. In recent years, Endo Pharmaceuticals has elevated itself from a marketer of...

2010-07-15 07:30:00

CHADDS FORD, Pa., July 15 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) announced today the completion of its acquisition of HealthTronics, Inc. (Nasdaq: HTRN), a leading U.S. provider of urological products and services, located in Austin, Texas. On July 12, 2010, Endo acquired HealthTronics through a tender offer and subsequent merger upon which HealthTronics became a wholly owned subsidiary of Endo. "The HealthTronics acquisition marks an important step forward in...

2010-07-12 07:30:00

CHADDS FORD, Pa., July 12 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) today announced the expiration of the subsequent offering period of the tender offer by its wholly owned subsidiary, HT Acquisition Corp., for all of the outstanding shares of common stock of HealthTronics, Inc. (Nasdaq: HTRN). American Stock Transfer & Trust Company, the depositary for the tender offer, has advised Endo that, as of 5:00 p.m., New York City time, on July 9, 2010, the expiration of...

2010-07-01 01:15:00

CHADDS FORD, Pa., July 1 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq: ENDP) has submitted a complete response to the U.S. Food and Drug Administration (FDA) following the company's receipt of a Complete Response letter in October 2009 related to the New Drug Application (NDA) submission for FORTESTA(TM) (testosterone) 2% gel. The company's Class 2 resubmission is the next step in its intention to offer FORTESTA as a treatment option in the United States for men diagnosed with...